Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Meyer

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Acta Biologica Et Medica Germanica|January 1, 1972
[Problem of interaction between proteins and sulfanilamides]F P Meyer
The American Journal of Medicine|April 7, 1998
No primary prevention by pravastatinF P Meyer
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Meta-analysis of beta-blockers in heart failureF P Meyer
MMW Fortschritte Der Medizin|March 10, 2001
[RR > 160/100 mmHg. Definitely an antihypertensive drug?]F P Meyer
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Indicative therapeutic and toxic drug concentrations in plasma: a tabulationF P Meyer
Lancet (London, England)|October 7, 2000
Comparison of losartan and captopril in ELITE IIF P Meyer
The New England Journal of Medicine|April 17, 1999
Pravastatin and coronary heart diseaseF P Meyer
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[The use of anti-epileptic agents and the determination of their blood level]F P Meyer, H Walther
Die Pharmazie|January 1, 1995
[Special qualification of a photometric procedure for determination of salicylic acid in therapeutic drug monitoring]J Martens, F P Meyer
Acta Biologica Et Medica Germanica|January 1, 1971
[Substance and species specific differences in acute toxicity of some sulfanilamides for mouse and rat]F P Meyer, W Oelszner
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Acta Biologica Et Medica Germanica|January 1, 1972
[Problem of interaction between proteins and sulfanilamides]F P Meyer
The American Journal of Medicine|April 7, 1998
No primary prevention by pravastatinF P Meyer
International Journal of Clinical Pharmacology and Therapeutics|January 5, 2002
Meta-analysis of beta-blockers in heart failureF P Meyer
MMW Fortschritte Der Medizin|March 10, 2001
[RR > 160/100 mmHg. Definitely an antihypertensive drug?]F P Meyer
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Indicative therapeutic and toxic drug concentrations in plasma: a tabulationF P Meyer
Lancet (London, England)|October 7, 2000
Comparison of losartan and captopril in ELITE IIF P Meyer
The New England Journal of Medicine|April 17, 1999
Pravastatin and coronary heart diseaseF P Meyer
Zeitschrift Fur Arztliche Fortbildung|August 1, 1980
[The use of anti-epileptic agents and the determination of their blood level]F P Meyer, H Walther
Die Pharmazie|January 1, 1995
[Special qualification of a photometric procedure for determination of salicylic acid in therapeutic drug monitoring]J Martens, F P Meyer
Acta Biologica Et Medica Germanica|January 1, 1971
[Substance and species specific differences in acute toxicity of some sulfanilamides for mouse and rat]F P Meyer, W Oelszner
Pageof 13